NCBI Taxonomy: 2686335

Alvaradoa haitiensis (ncbi_taxid: 2686335)

found 34 associated metabolites at species taxonomy rank level.

Ancestor: Alvaradoa

Child Taxonomies: none taxonomy data.

Chrysophanol

1,8-DIHYDROXY-3-METHYL-9,10-DIHYDROANTHRACENE-9,10-DIONE

C15H10O4 (254.0579)


Chrysophanic acid appears as golden yellow plates or brown powder. Melting point 196 °C. Slightly soluble in water. Pale yellow aqueous solutions turn red on addition of alkali. Solutions in concentrated sulfuric acid are red. (NTP, 1992) Chrysophanol is a trihydroxyanthraquinone that is chrysazin with a methyl substituent at C-3. It has been isolated from Aloe vera and exhibits antiviral and anti-inflammatory activity. It has a role as an antiviral agent, an anti-inflammatory agent and a plant metabolite. It is functionally related to a chrysazin. Chrysophanol is a natural product found in Rumex dentatus, Ageratina altissima, and other organisms with data available. See also: Frangula purshiana Bark (part of). A trihydroxyanthraquinone that is chrysazin with a methyl substituent at C-3. It has been isolated from Aloe vera and exhibits antiviral and anti-inflammatory activity. Constituent of Rumex, Rheum subspecies Chrysophanol is found in dock, garden rhubarb, and sorrel. Chrysophanol is found in dock. Chrysophanol is a constituent of Rumex, Rheum species D009676 - Noxae > D009153 - Mutagens Chrysophanol (Chrysophanic acid) is a natural anthraquinone, which inhibits EGF-induced phosphorylation of EGFR and suppresses activation of AKT and mTOR/p70S6K. Chrysophanol (Chrysophanic acid) is a natural anthraquinone, which inhibits EGF-induced phosphorylation of EGFR and suppresses activation of AKT and mTOR/p70S6K.

   

Alvaradoin F

Alvaradoin F

C22H22O9 (430.1264)


A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a (1-O-acetyl)-alpha-L-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10R stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.

   

Alvaradoin M

Alvaradoin M

C25H26O9 (470.1577)


A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 3-O-senecioyl-alpha-L-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10S stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.

   

Alvaradoin H

Alvaradoin H

C27H28O10 (512.1682)


A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 1-O-acetyl-3-O-senecioyl-alpha-L-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10S stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.

   

Alvaradoin L

Alvaradoin L

C25H26O9 (470.1577)


A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 2-O-senecioyl-alpha-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10S stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.

   

Chrysophanic acid

1,8-dihydroxy-3-methylanthracene-9,10-dione

C15H10O4 (254.0579)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.321 D009676 - Noxae > D009153 - Mutagens relative retention time with respect to 9-anthracene Carboxylic Acid is 1.322 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.318 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.324 Chrysophanol (Chrysophanic acid) is a natural anthraquinone, which inhibits EGF-induced phosphorylation of EGFR and suppresses activation of AKT and mTOR/p70S6K. Chrysophanol (Chrysophanic acid) is a natural anthraquinone, which inhibits EGF-induced phosphorylation of EGFR and suppresses activation of AKT and mTOR/p70S6K.

   

Crysophanol

Chrysophanic acid (1,8-dihydroxy-3-methylanthraquinone)

C15H10O4 (254.0579)


D009676 - Noxae > D009153 - Mutagens Chrysophanol (Chrysophanic acid) is a natural anthraquinone, which inhibits EGF-induced phosphorylation of EGFR and suppresses activation of AKT and mTOR/p70S6K. Chrysophanol (Chrysophanic acid) is a natural anthraquinone, which inhibits EGF-induced phosphorylation of EGFR and suppresses activation of AKT and mTOR/p70S6K.

   

alvaradoin E

alvaradoin E

C22H22O9 (430.1264)


A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a (1-O-acetyl)-alpha-L-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10S stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.

   

alvaradoin G

alvaradoin G

C27H28O10 (512.1682)


A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 1-O-acetyl-3-O-senecioyl-alpha-L-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10R stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.

   

Alvaradoin K

Alvaradoin K

C25H26O9 (470.1577)


A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 2-O-senecioyl-alpha-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10R stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.

   

Alvaradoin J

Alvaradoin J

C27H28O11 (528.1632)


A C-glycosyl compound that is 1,8,10-trihydroxy-3-methylanthracen-9-one substituted by a 1-O-acetyl-3-O-senecioyl-alpha-L-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10S stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.

   

Alvaradoin I

Alvaradoin I

C27H28O11 (528.1632)


A C-glycosyl compound that is 1,8,10-trihydroxy-3-methylanthracen-9-one substituted by a 1-O-acetyl-3-O-senecioyl-alpha-L-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10R stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.

   

(2r,3r,4r,5r,6s)-2-(acetyloxy)-3,5-dihydroxy-6-[(9s)-4,5,9-trihydroxy-2-methyl-10-oxoanthracen-9-yl]oxan-4-yl 3-methylbut-2-enoate

(2r,3r,4r,5r,6s)-2-(acetyloxy)-3,5-dihydroxy-6-[(9s)-4,5,9-trihydroxy-2-methyl-10-oxoanthracen-9-yl]oxan-4-yl 3-methylbut-2-enoate

C27H28O11 (528.1632)


   

2-(4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl)-3,5,6-trihydroxyoxan-4-yl 3-methylbut-2-enoate

2-(4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl)-3,5,6-trihydroxyoxan-4-yl 3-methylbut-2-enoate

C25H26O9 (470.1577)


   

(2s,3r,4r,5r,6r)-3,4,5-trihydroxy-6-[(9r)-4,9,10-trihydroxy-2-methyl-5-oxo-6,7-dihydroanthracen-9-yl]oxan-2-yl acetate

(2s,3r,4r,5r,6r)-3,4,5-trihydroxy-6-[(9r)-4,9,10-trihydroxy-2-methyl-5-oxo-6,7-dihydroanthracen-9-yl]oxan-2-yl acetate

C22H24O10 (448.1369)


   

(2s,3r,4r,5r,6r)-6-[(9s)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-2,4,5-trihydroxyoxan-3-yl 3-methylbut-2-enoate

(2s,3r,4r,5r,6r)-6-[(9s)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-2,4,5-trihydroxyoxan-3-yl 3-methylbut-2-enoate

C25H26O9 (470.1577)


   

(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-[(9s)-4,5,9-trihydroxy-2-methyl-10-oxoanthracen-9-yl]oxan-2-yl acetate

(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-[(9s)-4,5,9-trihydroxy-2-methyl-10-oxoanthracen-9-yl]oxan-2-yl acetate

C22H22O10 (446.1213)


   

(2s,3r,4r,5r,6r)-6-[(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-2,4,5-trihydroxyoxan-3-yl 3-methylbut-2-enoate

(2s,3r,4r,5r,6r)-6-[(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-2,4,5-trihydroxyoxan-3-yl 3-methylbut-2-enoate

C25H26O9 (470.1577)


   

(2r,3r,4r,5s,6s)-6-[(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-2,4,5-trihydroxyoxan-3-yl 3-methylbut-2-enoate

(2r,3r,4r,5s,6s)-6-[(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-2,4,5-trihydroxyoxan-3-yl 3-methylbut-2-enoate

C25H26O9 (470.1577)


   

6-(4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl)-2,4,5-trihydroxyoxan-3-yl 3-methylbut-2-enoate

6-(4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl)-2,4,5-trihydroxyoxan-3-yl 3-methylbut-2-enoate

C25H26O9 (470.1577)


   

2-(acetyloxy)-6-(4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl)-3,5-dihydroxyoxan-4-yl 3-methylbut-2-enoate

2-(acetyloxy)-6-(4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl)-3,5-dihydroxyoxan-4-yl 3-methylbut-2-enoate

C27H28O10 (512.1682)


   

6-(4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl)-3,4,5-trihydroxyoxan-2-yl acetate

6-(4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl)-3,4,5-trihydroxyoxan-2-yl acetate

C22H22O9 (430.1264)


   

(2r,3r,4r,5s,6r)-2-(acetyloxy)-6-[(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-3,5-dihydroxyoxan-4-yl 3-methylbut-2-enoate

(2r,3r,4r,5s,6r)-2-(acetyloxy)-6-[(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-3,5-dihydroxyoxan-4-yl 3-methylbut-2-enoate

C27H28O10 (512.1682)


   

(2s,3r,4r,5s,6s)-6-[(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-3,4,5-trihydroxyoxan-2-yl acetate

(2s,3r,4r,5s,6s)-6-[(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-3,4,5-trihydroxyoxan-2-yl acetate

C22H22O9 (430.1264)


   

(2r,3r,4r,5r,6s)-2-(acetyloxy)-3,5-dihydroxy-6-[(9r)-4,5,9-trihydroxy-2-methyl-10-oxoanthracen-9-yl]oxan-4-yl 3-methylbut-2-enoate

(2r,3r,4r,5r,6s)-2-(acetyloxy)-3,5-dihydroxy-6-[(9r)-4,5,9-trihydroxy-2-methyl-10-oxoanthracen-9-yl]oxan-4-yl 3-methylbut-2-enoate

C27H28O11 (528.1632)


   

(2s,3r,4r,5r,6s)-2-(acetyloxy)-6-[(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-3,5-dihydroxyoxan-4-yl 3-methylbut-2-enoate

(2s,3r,4r,5r,6s)-2-(acetyloxy)-6-[(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-3,5-dihydroxyoxan-4-yl 3-methylbut-2-enoate

C27H28O10 (512.1682)


   

(2s,3r,4r,5s,6s)-6-[(9s)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-3,4,5-trihydroxyoxan-2-yl acetate

(2s,3r,4r,5s,6s)-6-[(9s)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-3,4,5-trihydroxyoxan-2-yl acetate

C22H22O9 (430.1264)


   

(2s,3r,4r,5r,6r)-3,4,5-trihydroxy-6-[(9s)-4,5,9-trihydroxy-2-methyl-10-oxoanthracen-9-yl]oxan-2-yl acetate

(2s,3r,4r,5r,6r)-3,4,5-trihydroxy-6-[(9s)-4,5,9-trihydroxy-2-methyl-10-oxoanthracen-9-yl]oxan-2-yl acetate

C22H22O10 (446.1213)


   

(2r,3r,4r,5s,6s)-6-[(9s)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-2,4,5-trihydroxyoxan-3-yl 3-methylbut-2-enoate

(2r,3r,4r,5s,6s)-6-[(9s)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-2,4,5-trihydroxyoxan-3-yl 3-methylbut-2-enoate

C25H26O9 (470.1577)


   

2-(acetyloxy)-3,5-dihydroxy-6-(4,5,9-trihydroxy-2-methyl-10-oxoanthracen-9-yl)oxan-4-yl 3-methylbut-2-enoate

2-(acetyloxy)-3,5-dihydroxy-6-(4,5,9-trihydroxy-2-methyl-10-oxoanthracen-9-yl)oxan-4-yl 3-methylbut-2-enoate

C27H28O11 (528.1632)


   

(2s,3r,4r,5r,6s)-2-(acetyloxy)-6-[(9s)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-3,5-dihydroxyoxan-4-yl 3-methylbut-2-enoate

(2s,3r,4r,5r,6s)-2-(acetyloxy)-6-[(9s)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-3,5-dihydroxyoxan-4-yl 3-methylbut-2-enoate

C27H28O10 (512.1682)


   

(2r,3r,4r,5r,6r)-6-[(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-3,4,5-trihydroxyoxan-2-yl acetate

(2r,3r,4r,5r,6r)-6-[(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-3,4,5-trihydroxyoxan-2-yl acetate

C22H22O9 (430.1264)


   

(2s,3r,4r,5r,6r)-2-[(9s)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-3,5,6-trihydroxyoxan-4-yl 3-methylbut-2-enoate

(2s,3r,4r,5r,6r)-2-[(9s)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-3,5,6-trihydroxyoxan-4-yl 3-methylbut-2-enoate

C25H26O9 (470.1577)


   

(2r,3s,4r,5r,6s)-2-[(9s)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-3,5,6-trihydroxyoxan-4-yl 3-methylbut-2-enoate

(2r,3s,4r,5r,6s)-2-[(9s)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-3,5,6-trihydroxyoxan-4-yl 3-methylbut-2-enoate

C25H26O9 (470.1577)